Private Capital Group’s Haemonetics HAE Stock Holding History

Private Capital Group’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1K	Hold	14	–	–	﹤0.01%	1710
2022 Q1	$1K	Hold	14	–	–	﹤0.01%	1940
2021 Q4	$1K	Hold	14	–	–	﹤0.01%	1937
2021 Q3	$1K	Hold	14	–	–	﹤0.01%	1994
2021 Q2	$1K	Hold	14	–	–	﹤0.01%	1966
2021 Q1	$2K	Sell	14 -80	-85%	-$9.9K	﹤0.01%	1756
2020 Q4	$11K	Buy	94 +80	+571%	+$8.61K	﹤0.01%	1370
2020 Q3	$1K	Sell	14 -545	-97%	-$47.6K	﹤0.01%	1844
2020 Q2	$50K	Buy	559 +215	+63%	+$21.7K	0.01%	706
2020 Q1	$34K	Buy	344 +324	+1,620%	+$35.1K	0.01%	789
2019 Q4	$2K	Hold	20	–	–	﹤0.01%	1692
2019 Q3	$3K	Sell	20 -234	-92%	-$29.7K	﹤0.01%	1801
2019 Q2	$23K	Buy	254 +226	+807%	+$22.2K	0.01%	1018
2019 Q1	$2K	Sell	28 -2	-7%	-$182	﹤0.01%	1893
2018 Q4	$3K	Sell	30 -25	-45%	-$2.63K	﹤0.01%	1773
2018 Q3	$6K	Sell	55 -199	-78%	-$20.6K	﹤0.01%	1643
2018 Q2	$22K	Sell	254 -55	-18%	-$4.64K	﹤0.01%	1071
2018 Q1	$23K	Buy	309 +3	+1%	+$206	0.01%	1007
2017 Q4	$18K	Buy	+306	New	+$16.1K	﹤0.01%	1114

Other funds holding HAE

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

LCP

LGT Capital Partners Pfaeffikon, Switzerland $1.97B AUM 15.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Private Capital Group's HAE Position: Q2 2022 in Review

Private Capital Group held its Haemonetics (HAE) position steady in Q2 2022 at 14 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1710.

Private Capital Group first reported a position in HAE in Q4 2017 and has held it in 19 quarters since. The position peaked at $50K in Q2 2020. 241 funds tracked by Wall St. Rank hold HAE as of Q2 2022.

Private Capital Group held 14 shares of Haemonetics worth $1K as of Q2 2022.
Private Capital Group left its Haemonetics share count unchanged in Q2 2022.
Haemonetics made up ﹤0.01% of Private Capital Group's portfolio in Q2 2022, its #1710 holding.
Private Capital Group first reported a position in Haemonetics in Q4 2017 and has held it in 19 quarters since.
Private Capital Group's Haemonetics position peaked at $50K in Q2 2020.
241 funds tracked by Wall St. Rank held Haemonetics as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.